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Purpose: To determine the prevalence and characteristics of neuropathic pain (NP) 
in patients with lumbar spinal stenosis (LSS) according to subgroup analysis of 
symptoms. Materials and Methods: We prospectively enrolled subjects with LSS 
(n=86) who were scheduled to undergo spinal surgery. The patients were divided 
into two groups according to a chief complaint of radicular pain or neurogenic clau-
dication. We measured patient’s pain score using the visual analog scale (VAS), Os-
westry Disability Index (ODI) and Leads Assessment of Neuropathic Symptoms 
and Signs (LANSS). According to LANSS value, the prevalence of NP component 
pain in patients with LSS was assessed. Statistical analysis was performed to find 
the relationship between LANSS scores and the other scores. Results: From our 
sample of 86 patients, 31 (36.0%) had a NP component, with 24 (63.4%) in the ra-
dicular pain group having NP. However, only seven patients (15.6%) in the neuro-
genic claudication group had NP. The LANSS pain score was not significantly cor-
related with VAS scores for back pain, but did correlate with VAS scores for leg 
pain (R=0.73, p<0.001) and with ODI back pain scores (R=0.54, p<0.01). Conclu-
sion: One-third of the patients with LSS had a NP component. The presence of ra-
dicular pain correlated strongly with NP. The severity of leg pain and ODI score 
were also closely related to a NP component. This data may prove useful to under-
standing the pain characteristics of LSS and in better designing clinical trials for NP 
treatment in patients with LSS.
Key Words:   Neuropathic pain, spinal stenosis, visual analog scale, Oswestry Dis-
ability Index, Leads Assessment of Neuropathic Symptoms and Signs
INTRODUCTION
The etiology of chronic pain disorders is heterogeneous, comprising nociceptive, 
neuropathic, and mixed pain pathways. Neuropathic pain (NP) has been defined as 
pain initiated or caused by a primary lesion or dysfunction of the nervous system1 
and which may arise as a consequence of a lesion or disease affecting the somato-
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cits.13-15 Attal, et al.14 found that over 30% of patients with 
chronic LBP had neuropathic limb pain on the DN4 ques-
tionnaire. Moreover, over 70% of patients with neurologic 
deficits had NP. However, few have studied NP pain compo-
nents in patients with spinal stenosis. In this study, we aimed 
to determine the extent of the NP component using the 
Leads Assessment of Neuropathic Symptoms and Signs 
(LANSS) scale and to identify the relationships between NP 
and symptom characteristics in patients with LSS scheduled 
to undergo surgery.
MATERIALS AND METHODS
Study design and participants
This prospective study was performed between March 2010 
and May 2012. Eighty-six consecutive patients with spinal 
stenosis who were scheduled to undergo spinal surgery were 
enrolled. All patients had moderate to severe symptoms, 
such as radicular leg pain and neurogenic claudication, relat-
ed to LSS. MRI was performed in all patients to obtain con-
firmatory cross-sectional imaging of the LSS at one or more 
levels.16,17 Exclusion criteria included cauda equina syn-
drome, spinal infection, tumor, or spinal fracture. Patients 
with peripheral arterial occlusive diseases, severe diabetic 
neuropathy, or diabetic foot were also excluded from this 
study. All patients who agreed to be involved in this study 
provided written informed consent. The Institutional Re-
view Board of our hospital approved the study. All patients 
completed self-assessment questionnaires and provided de-
mographic and clinical information, including socio-demo-
graphic data and symptoms related to LSS. Patients were 
characterized as having predominant radicular pain or neu-
rogenic claudication. Patients with radicular pain that did 
not improve upon flexion were classified into the radicular 
pain group. 
Measures
The intensity of pain in the back and/or legs was measured 
using a 100-mm visual analog scale (VAS) on which a score 
of 0 indicates no pain and a score of 100 indicates the worst 
conceivable pain. Health-related quality of life (HRQoL) 
was assessed using the Korean version of the Oswestry Dis-
ability Index (ODI).18 The LANSS was used to assess the sen-
sory descriptions of pain provided by the patient and from a 
bedside examination of sensory dysfunction. Positive scores 
on the LANSS identified patients with pain that was predom-
sensory system. Diabetic neuropathy, post-herpetic neural-
gia, trigeminal neuralgia, and post-spinal cord injury pain 
are classic examples of NP.2 It is believed that NP serves an 
important role in the pathogenesis of many diseases related 
to the spine. However, the diagnosis of NP remains clinical 
and is based on a characteristic symptom profile and diag-
nostic tests. 
Low back pain (LBP) is one of the most challenging 
chronic pain disorders to treat. Chronic LBP can involve 
both the back and the legs.3 In addition, both neuropathic 
and nociceptive pain pathways contribute to lower back and 
associated leg pain. Generally, the leg pain component is 
due to NP, and the back pain component is due to nocicep-
tive mechanisms.4 Moreover, about 20% of patients with 
LBP pain suffer from a NP component.5 It is important to re-
member that LBP is not a diagnosis but rather describes a 
constellation of symptoms. LBP is produced by numerous 
conditions, resulting in difficulty in understanding and antic-
ipating the clinical course. Due to the heterogeneous patho-
physiology of LBP, some clinical pain trials have obtained 
poorer results than other studies of NP conditions, such as 
diabetic neuropathy.6,7 This highlights a need to better char-
acterize the specific pathophysiology of LBP in order to es-
tablish optimal treatment regimens. For example, a medica-
tion indicated to treat NP, such as pregabalin, might be 
considered a first-line drug for patients with lumbar spinal 
stenosis (LSS) when NP is a significant component of the 
overall presenting symptom complex.
LSS is a clinical syndrome caused by narrowing of the spi-
nal canal with encroachment on neural structures surround-
ing bone and soft tissue. Its clinical symptoms vary but ap-
pear as a result of neurovascular mechanisms, nerve root 
excitation, or mechanical compression of the spinal canal. 
These mechanisms can concur simultaneously. Patients 
typically present either with LBP and radicular leg pain or 
with neurogenic claudication. Because lumbar flexion in-
creases the available space in the spinal canal, patients usu-
ally complain of clamping pain in the buttocks and legs 
when walking, which disappears with sitting or lumbar 
flexion. However, radicular pain, which may not improve 
with flexion, can also be attributed to spinal stenosis.8-10
Spinal stenosis is the most common reason for lumbar 
spine surgery in middle-age and elderly populations, likely 
because of the degenerative pathogenesis.11,12 Some studies 
on the prevalence of NP components in patients with sciati-
ca or radiculopathy have revealed a higher prevalence of NP 
in patients with severe radiculopathy or neurologic defi-
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centages. Quantitative variables are described as means with 
standard deviation. We divided participants into two groups 
by their main symptoms. Variables were analyzed using 
Fisher’s exact test or the Mann-Whitney U test. The relation-
ships between LANSS score and co-morbidities including 
diabetes mellitus (DM) and hypertension were assessed us-
ing logistic regression analysis. The correlations between 
LANSS score and continuous variables, such as the VAS 
and ODI scores, were calculated using Spearman’s correla-
tion coefficient. SPSS version 18.0 for Windows (SPSS 
Inc., Chicago, IL, USA) was used for all statistical analyses. 
All p-values<0.05 were accepted as statistically significant. 
inantly neuropathic in origin. The sensitivity and specificity 
were 85% and 80%, respectively.19-21 All patients were as-
sessed using the LANSS pain scale. A score <12 indicated 
that neuropathic mechanisms were unlikely, whereas a score 
≥12 suggested that neuropathic mechanisms were likely (Ta-
ble 1).19 The primary focus of this study was to determine the 
prevalence of NP components in patients with LSS using 
the LANSS pain scale. The secondary focus was to explore 
potential relationships between clinical symptoms and NP.
Statistical analysis
All qualitative variables are reported as frequencies and per-
Table 1. Leads Assessment of Neuropathic Symptoms and Signs Scale
A. Pain questionnaire
1)  Does your pain feel like strange, unpleasant sensations in your skin? Words like pricking, tingling, pins and needles might  
 describe these sensations.  
     No: my pain doesn’t really feel like this (0) 
     Yes: I get these sensations quite a lot (5)
2)  Does your pain make the skin in the painful area look different from normal? Words like mottled or looking more red or pink  
 might describe the appearance.  
     No: my pain doesn’t affect the color of my skin (0) 
     Yes: I’ve noticed that the pain does make my skin look different (5)
3)  Does your pain make the affected skin abnormally sensitive to touch? Getting unpleasant sensations when lightly stroking the  
 skin, or getting pain when wearing tight clothes might describe the abnormal sensitivity.  
     No: my pain doesn’t make my skin abnormally sensitive in that area (0) 
     Yes: my skin seems abnormally sensitive to touch in that area (3)
4)  Does your pain come on suddenly and in bursts for no apparent reason when you’re still? Words like electric shocks,  
 jumping and bursting describe these sensations.  
     No: my pain doesn’t really feel like this (0) 
     Yes: I get these sensations quite a lot (2)
5)  Does your pain feel as if the skin temperature in the painful area has changed abnormally? Words like hot and bursting describe  
 these sensations. 
     No: I don’t really get these sensations (0) 
     Yes: I get these sensations quite a lot (1)
B. Sensory test
1)  Allodynia 
 Examine the response to lightly stroking cotton wool across the non-painful area and then the painful area. If normal sensations  
 are experienced in the non-painful site, but pain or unpleasant sensations (tingling, nausea) are experienced in the painful area  
 when stroking, allodynia in present.  
     No: normal sensation in both area (0) 
     Yes: allodynia in painful area only (5)
2)  Altered pin-prick threshold (PPT) 
 Determine the pin-prick threshold by comparing the response to 23 gauge (blue) needle mounted inside a 2 mL syringe barrel paced  
 gently on to skin in a non-painful and then painful areas. If a sharp pin prick is felt in the non-painful area, but a different sensation  
 is experienced in the painful area e.g. none/blunt only (raised PPT) or a very painful sensation (lowered PPT), an altered PPT is  
 present. If a pinprick is not felt in either area, mount the syringe onto the needle to increase the weight and repeat. 
     No: equal sensation in both areas (0) 
     Yes: altered PPT in painful area (3)
Scoring: add values in parentheses for sensory description and examination findings to obtain overall score. Total score (maximum 24). If score<12, neuropathic 
mechanisms are unlikely to be contribution to the patient’s pain. If score≥12, neuropathic mechanisms are likely to be contributing to the patient’s pain.
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there were 45 patients with neurogenic claudication. VAS 
scores on the leg were significantly higher in the radicular 
pain group, while VAS scores for the back were not signifi-
cantly different between the two groups. Twenty-four pa-
tients (63.4%) in the radicular pain group had NP, while 
only seven patients (15.6%) in the neurogenic claudication 
group had NP (p<0.05) (Table 3, Fig. 1).
A significant correlation was observed between LANSS 
and VAS scores for leg pain (R=0.73, p<0.001) and between 
LANSS and ODI scores (R=0.54, p<0.01). VAS scores for 
back pain, age, sex, duration of symptoms, and level of in-
volvement did not correlate significantly with LANSS score 
(Table 4). Also, co-morbidities, including DM or hyperten-
sion, were not significantly related with LANSS scores (Ta-
ble 5).
DISCUSSION
Lumbar spinal stenosis causes a range of clinical symptoms, 
including back pain, radicular pain, neurogenic claudication, 
and neurologic deficits.22 The heterogeneity of the clinical 
symptoms and pathophysiology of LSS contributes to the 
difficulty in understanding the actual source of pain. Attal, et 
al.14 demonstrated a higher prevalence of NP components in 
patients with chronic LBP. However, that study did not dif-
ferentiate between the causes of the chronic LBP. In this 
RESULTS
Eighty-six patients (34 men, 52 women; mean age: 66.3± 
5.9) were included in this study. All patients were diagnosed 
with LSS using MRI during the preoperative period. The 
most frequently involved level was L4‒5. The mean dura-
tion of symptoms was 9 months. The mean intensities of 
back and leg pain were 4.6±2.3 and 6.2±3.1, respectively. 
The mean ODI score was 23.4±12.7. The mean LANSS 
score was 7.2±5.6 (range: 0‒24). When organizing patients 
according to LANSS guidelines,19 31 patients (36.0%) had 
NP as indicated by scores ≥12 (Table 2). 
Seventy-eight percent of patients had both radicular pain 
and NC. All patients indicated either a predominance of ra-
dicular pain over NC or vice versa. There were 41 patients 
with predominant radicular pain and 45 patients with pre-
dominant neurogenic claudication; there were no significant 
differences in sex, age, BMI, or co-morbidities between 
these two groups. Forty-one patients were classified as hav-
ing primary radicular pain symptoms or predominant radic-
ular pain. Grouping primary and predominant NC together, 
Table 2. Demographic Data
Number of patients 86
Sex (M/F) 34/52
Age (yr-old) 66.3±5.9*
Co-morbidity (%)
Hypertension    61 (70.9)
Diabetes mellitus (type II)    49 (56.7)
Level (%)
L2‒3 5 (5)
L3‒4   9 (10)
L4‒5 39 (45)
L5‒S1 17 (20)
Multiple levels 26 (30)
Symptoms (%)
Radicular pain alone 8 (9)
Neurogenic claudication alone 11 (13)
Combined 67 (78)
Pain scores
VAS back (0‒10)   4.23±1.35*
VAS leg (0‒10)   5.93±1.64*
ODI (0‒45) 24.76±5.74*
LANSS (0‒25)   8.26±5.36*
Over 12 (%) 31 (36)
Less than 12 (%) 55 (64)
LANSS, Leads Assessment of Neuropathic Symptoms and Signs; ODI, Os-
westry Disability Index; VAS, visual analog scale.
*Mean±standard deviation.
Table 3. Clinical Characteristics of the Patient Groups
Group 1 
(radicular pain)
Group 2 
(neurogenic  
claudication)
p value
Number 41 45
Sex (M/F) 15/26 19/26 NS†
Age 65.48±6.18 66.98±5.61 NS*
BMI 23.8±4.2 22.9±6.4 NS*
Co-morbidity
Hypertension 25 31 NS†
DM type II 22 27 NS†
Pain score
VAS back   4.20±1.31   4.29±1.41 NS*
VAS leg   6.39±1.83   5.52±1.34    0.029*
ODI 26.07±6.78 23.56±4.34 NS*
LANSS 10.14±6.43   6.53±3.40    0.035*
Over 12 24 (63.4%) 7 (15.6%) <0.001†
DM, diabetes mellitus; LANSS, Leads Assessment of Neuropathic Symp-
toms and Signs; NS, not significant; ODI, Oswestry Disability Index; VAS, 
visual analog scale.
*Mann-Whitney U test.
†Fisher’s exact test.
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leg pain but not back pain. Moreover, radicular pain in pa-
tients with LSS seemed to be mainly related to a NP compo-
nent. Compared to patients in the neurogenic claudication 
group, more severe leg pain was demonstrated in patients in 
the radiculopathy group. Kovacs, et al.10 reviewed and re-
ported that patients with radicular pain show poorer out-
comes, despite being amenable to surgery. This might be 
due to the radicular symptoms belonging more to the NP 
group, with its sensitization of peripheral nerves or the cen-
tral nervous system, than to the nociceptive pain group. This 
may represent a mechanism in patients with radicular pain 
that is more difficult to treat. 
LSS can present in several ways but often presents as neu-
rogenic claudication or radicular pain. Neurogenic claudica-
tion in patients with LSS is characterized by bilateral or uni-
lateral thigh or calf pain or weakness when walking.24 It is 
thought that narrowing of the spinal canal results from de-
generative changes of the spine, leading to compression or 
ischemia of the lumbosacral nerve roots.22,25,26 In contrast, 
radicular pain (e.g., sciatica) is thought to be due to nerve 
root irritation from chemical or mechanical inflammation or 
from direct neural compression in the central canal.27,28 
Lumbar flexion does not improve radiculopathy, and the 
symptoms do not always occur independently but rather can 
be mixed. In our study, patients with LSS also complained 
of radicular pain and/or neurogenic claudication; however, 
NP appeared to be more related to radicular pain and not 
neurogenic claudication. A higher VAS score for leg pain 
was closely related to higher LANSS score. On correlation 
analysis, ODI score was also correlated with LANSS score, 
suggesting that NP results in more leg than back pain and 
can significantly worsen functional status. As reported by 
Freynhagen, et al.,4,5,29 leg symptoms are the result of NP, 
but back pain is not. However, in regard to leg symptoms, 
radiculopathy was more strongly related to a NP compo-
nent. Our study suggests that degenerative spinal disorders 
such as LSS, which produce back and leg pain, have both 
study, we found a higher prevalence (36%) of NP compo-
nents in patients with LSS than that reported in other studies 
of patients with LBP.14,20 In subgroup analysis, patients in the 
radicular pain group had higher LANSS scores than patients 
in the claudication group. Almost two-thirds of patients in 
the radicular pain group had LANSS scores over 12, indi-
cating NP; meanwhile, only seven patients (15.6%) in the 
claudication group had LANSS scores consistent with NP. 
Several screening tools have been introduced to identify 
NP. The LANSS pain scale was the first tool to be devel-
oped and contains five symptom items and two clinical ex-
amination items. The LANSS pain scale can distinguish pa-
tients with NP from those with nociceptive pain with high 
reliability and validity.19,20 Adequate psychometric evidence 
has also been demonstrated for the measurement of treat-
ment effects.20,23 
In the present study, a NP component was correlated with 
Table 4. Correlation between Pain or Functional Scores and 
LANSS Scores in Patients with Lumbar Spinal Stenosis 
(Spearman’s Correlation Test) 
LANSS
R p value
VAS back pain -0.133 0.26
VAS leg pain 0.728 <0.001
Duration of symptoms 0.183 0.41
ODI 0.544 <0.001
Sex 0.212 0.26
Age -0.097 0.37
LANSS, Leads Assessment of Neuropathic Symptoms and Signs; ODI, Os-
westry Disability Index; VAS, visual analog scale.
p<0.05 is statistically significant.
Table 5. Correlation between Co-Morbidities and LANSS 
Scores in Patients with Lumbar Spinal Stenosis
LANSS
Adjusted OR (95% CI) p value
DM type II 0.544 (0.131‒2.266) 0.341
Hypertension 0.261 (0.021‒0.539) 0.129
DM, diabetes mellitus; LANSS, Leads Assessment of Neuropathic Symp-
toms and Signs.
Multivariate Logistic regression analysis: all tested variables adjusting for 
age, sex, and BMI.
Fig. 1. Proportion of patients with neuropathic pain by group (neuropathic 
pain was defined as a LANSS score greater than or equal to 12). LANSS, 
Leads Assessment of Neuropathic Symptoms and Signs.
50
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In summary, one-third of patients with LSS had a NP 
component. Radicular pain correlated more strongly with 
NP than neurogenic claudication. The severity of leg pain 
and ODI score also demonstrated strong relationships with a 
NP component. These results will be useful to understand-
ing the characteristics of pain in LSS and in designing future 
clinical drug trials. 
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